Genetic Testing Gets a Boost From Medco(MHS)

by | May 19, 2010 | BIOgraph

Diagnostic Medicine is on the Forefront Genetic tests and the new field of pharmacogenomics is getting marketing support from an unlikely source-Pharmacy Benefit Managers (PBM’s). Medco (MHS), a $60B revenue PBM ($26B Market Cap)with over 65M members has been...

Pin It on Pinterest